Back to News
Market Impact: 0.32

Pentair Q4 Net Income Falls, Sales Rise 5%

PNR
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsM&A & RestructuringCurrency & FX
Pentair Q4 Net Income Falls, Sales Rise 5%

Pentair reported Q4 continuing net income of $161.8M, or $0.98/share, versus $166.4M ($0.99) a year earlier, while adjusted EPS rose to $1.18 on adjusted income of $194.7M. Operating income increased 5% to $205M and net sales grew 5% to $1.021B (core sales +4% excluding currency, acquisitions and divestitures). For fiscal 2026 the company guided GAAP EPS of approximately $4.94–$5.09 and adjusted EPS of about $5.25–$5.40.

Analysis

Market structure: Pentair (PNR) beating modestly with core sales +4% and mid-single-digit operating income expansion signals steady end-market demand for water-treatment and flows. Winners include OEMs and aftermarket suppliers (PNR, Xylem/XYL) and municipal/residential water-equipment suppliers; losers are low-end commoditized pump makers who lose pricing power. On cross-assets, expect modest corporate credit spread tightening for high-quality industrials and a mild downward pressure on hedged USD revenues if dollar rallies >3% in 60 days, with limited commodity impact outside stainless/copper inputs. Risk assessment: Tail risks include sudden municipal funding cuts, a large warranty/recall, or tariffs on China-sourced components — each could cut margins by 200–400bps and EPS by >10% in a year. Immediate (days) risk is sentiment-driven; short-term (3–6 months) depends on FX and backlog conversion; long-term (12–36 months) driven by secular water infrastructure and M&A execution. Hidden dependencies: guidance assumes stable FX and no major divestiture; watch order backlog and gross margin mix as early-warning indicators. Key catalysts: upcoming quarterly order trends, any announced large municipal contracts, and FY2026 semi-annual cadence. Trade implications: Establish a tactical 2–3% long position in PNR over 2–6 weeks, scaling on pullbacks ≥5%; pair by shorting XYL equal-dollar for 3–12 months if Xylem shows weaker margin recovery (re-balance at 10% moves). Use a cost-controlled options play: buy a 9–12 month PNR call spread (long 1x nearer-term +5–10% OTM, short +25–30% OTM) to capture upside while capping volatility. Rotate 1–2% portfolio weight from commodity cyclical names into defensive industrials with water exposure (PNR, AWK) over the next quarter. Contrarian angle: Consensus treats this as a benign beat; market may underprice upside from margin leverage and aftermarket recurring revenue — if adjusted EPS reaches $5.25–5.40, a re-rate of 10–20% is plausible within 6–12 months. Conversely, the market is underestimating FX sensitivity: a USD move >3–5% would meaningfully compress EPS vs guidance. Historical parallel: prior Pentair restructurings delivered outsized returns when combined with steady organic growth; failure mode is botched M&A or missed large public contracts which would reverse sentiment quickly.